PMID: 6186896Jan 1, 1982

Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization

Microbiology and Immunology
D RobertL Dussourd D'Hinterland

Abstract

The vaccinating potency of ribosomal fractions of Klebsiella pneumoniae and Streptococcus pneumoniae as well as their ribosomal RNA and protein fractions has been studied with respect to their ability to induce cellular or humoral immunity. Experiments with transfer of serum or spleen cells from vaccinated animals have shown that anti-Klebsiella immunity is essentially cellular, while streptococcal immunity is exclusively humoral. Results have been discussed as a function of differential results for the various fractions under study.

References

Oct 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·D RobertH Wigzell

Citations

Mar 1, 1976·Infection and Immunity·H C Thompson, T K Eisenstein
Oct 1, 1971·Infection and Immunity·M R Venneman, L J Berry
Oct 1, 1971·Infection and Immunity·M R Venneman, L J Berry
Sep 1, 1971·FEBS Letters·J Janda, E Work
Jan 1, 1971·Infection and Immunity·H C Thompson, I S Snyder

Related Concepts

Bacterial Proteins
Mice, Inbred BALB C
Spleen
Vaccines
Klebsiella pneumoniae
Streptococcus
Humoral Immunity
Ribosomal RNA
Infection by Klebsiella Pneumoniae in Conditions Classified Elsewhere and of Unspecified Site
Bacterial Vaccines

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.